HUB.B up +0.30% percent right now. $HUB.B High is at 112.92

New Post Public Reply Private Reply Replies (0) Message Board

Nov 11, 2014 at 4:25 PM

HUB.B up +0.30% percent right now. $HUB.B High is at 112.92 and the Low 111.26 with current volume of 83,911.

Recent News posted below.

HUB.B Hubbell Inc B Recent Headline News

Hubbell's (HUB. Q3 Earnings In Line , Revenues Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 11:30AM CDT
Hubbell Inc.'s (HUB. third quarter earnings of $1.51 per share were in line with the Zacks Consensus Estimate and flat sequentially.
AXTI: 2.41 (+0.05), CHTR: 146.68 (+0.06), SIMO: 22.70 (-0.61), HUB.B: 112.39 (+0.59)

10.5% Return Seen to Date on SmarTrend Hubbell Call (HUB.
Comtex SmarTrend(R) - Wed Oct 29, 10:02AM CDT
SmarTrend identified a Downtrend for Hubbell (NYSE:HUB. on September 30th, 2014 at $121.00. In approximately 4 weeks, Hubbell has returned 10.46% as of today's recent price of $108.34.
HUB.B: 112.39 (+0.59)

Hubbell's (HUB. CEO David Nord on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 23, 1:10PM CDT

HUB.B: 112.39 (+0.59)

Hubbell (HUB. Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 23, 8:55AM CDT

HUB.B: 112.39 (+0.59)

Hubbell misses by $0.01
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 7:24AM CDT

HUB.B: 112.39 (+0.59)

Hubbell meets 3Q profit forecasts
Automated Insights - Thu Oct 23, 7:01AM CDT
SHELTON, Conn. (AP) _ Hubbell Inc. (HUB. on Thursday reported third-quarter net income of $89.6 million.
HUB.B: 112.39 (+0.59), HUB.A: 117.94 (-0.15)

Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Oct 22, 4:30PM CDT

CRS: 51.48 (unch), CAM: 58.97 (+0.35), LAZ: 49.28 (-0.08), JAH: 66.31 (-0.53), ASPS: 72.78 (+2.47), BBW: 18.42 (+0.42), LO: 61.90 (-0.24), CAB: 50.99 (+0.23), CFX: 53.81 (-0.66), FAF: 30.32 (-0.10), KKR: 21.76 (-0.08), AEP: 57.94 (-0.44), DNKN: 47.34 (+0.05), DO: 36.64 (-0.83), JAKK: 6.69 (+0.13), AAL: 43.44 (-0.39), DAN: 20.27 (-0.02), CAT: 102.53 (+0.32), CSH: 50.18 (+0.37), LSTR: 76.74 (-0.58), BHE: 24.09 (unch), ARG: 114.31 (+0.40), AVT: 43.84 (+0.26), ALV: 95.48 (+0.57), ALK: 56.14 (-0.18), BKU: 30.52 (-0.08), CELG: 107.85 (-0.16), CWEI: 86.77 (+2.72), BCC: 37.61 (+0.91), HERO: 1.61 (+0.04), AB: 26.40 (+0.05), DGX: 63.00 (+0.31), ALXN: 194.92 (-0.88), CHKP: 74.88 (+0.15), MDP: 50.66 (-0.18), ACAT: 33.32 (-0.65), GRUB: 34.13 (+0.61), JBLU: 12.96 (-0.13), CLI: 19.55 (-0.10), CVE: 25.01 (+0.17), CCE: 42.55 (-0.07), LUV: 39.37 (+0.25), DPS: 69.74 (-0.73), IVC: 16.07 (-0.11), GMT: 65.39 (+0.05), BC: 48.64 (-0.13), JNS: 14.45 (-0.73), DLX: 60.53 (-0.34), CMS: 33.26 (+0.06), LTM: 56.42 (-0.33), CS: 25.93 (-0.05), LLY: 67.85 (-0.50), BMS: 39.10 (-0.20), IMAX: 30.18 (+1.19), EQT: 96.29 (+0.50), GPI: 87.23 (+0.69), EQM: 88.10 (+0.88), GM: 31.35 (+0.23), CRI: 78.49 (+0.76), CMCSA: 52.96 (+0.01), HUB.B: 112.39 (+0.59)

Hubbell Down 10.5% Since SmarTrend Downtrend Call (HUB.
Comtex SmarTrend(R) - Wed Oct 22, 10:11AM CDT
SmarTrend identified a Downtrend for Hubbell (NYSE:HUB. on September 30th, 2014 at $121.00. In approximately 3 weeks, Hubbell has returned 10.46% as of today's recent price of $108.34.
HUB.B: 112.39 (+0.59)

Dividend Challengers (And Near-Challengers): 57 Increases Expected By New Year's Day
David Fish - at Seeking Alpha - Sat Oct 18, 5:51PM CDT

RKT: 55.99 (-0.10), TTC: 62.94 (-0.01), HST: 22.76 (unch), OCR: 69.01 (+0.28), HI: 34.65 (+0.23), MAIN: 32.18 (-0.07), MHLD: 12.61 (+0.16), PRU: 86.11 (-0.43), DEI: 27.84 (-0.69), PSA: 187.35 (-0.77), THG: 69.24 (+0.01), KKR: 21.76 (-0.08), RL: 171.07 (-0.85), VTR: 68.52 (-0.09), AEP: 57.94 (-0.44), EVR: 51.19 (-0.49), TECH: 91.71 (+0.61), ROK: 112.86 (+0.11), INGR: 80.30 (-0.26), WTI: 9.33 (+0.43), COR: 37.81 (-0.04), EXL: 12.91 (-0.11), UG: 19.21 (+0.21), BGS: 29.01 (-0.59), ESV: 39.43 (-0.49), APTS: 8.72 (-0.02), EL: 72.70 (-0.13), HEI: 53.36 (-1.06), GE: 26.38 (-0.09), BOKF: 68.22 (-0.42), SNA: 135.71 (-0.05), BCPC: 68.29 (+2.56), SBUX: 77.73 (+0.08), V: 249.73 (-0.48), KIM: 24.78 (-0.16), BBSI: 23.10 (-1.18), SIX: 40.27 (+0.34), EMCI: 33.28 (+0.13), CHS: 15.16 (+0.10), NEU: 389.13 (-0.84), BMR: 21.63 (-0.02), EMN: 84.33 (+0.49), PRA: 44.86 (-0.28), CBL: 18.97 (-0.43), CUBE: 20.95 (-0.15), DIS: 89.98 (+0.20), BMY: 58.72 (-0.09), ABC: 87.93 (+0.22), RCII: 31.64 (-0.03), WCN: 50.22 (-0.12), HCI: 43.72 (-0.19), MAC: 69.37 (-0.18), AMTD: 35.38 (+0.32), HUB.B: 112.39 (+0.59), JCI: 49.58 (+0.41)

Why Hubbell (HUB. Stock Is Declining Today
at The Street - Thu Oct 09, 10:03AM CDT
Hubbell (HUB. shares are down after analysts at Oppenheimer downgraded it to 'market perform' on Thursday.
HUB.B: 112.39 (+0.59)

Downgrade Alert for Hubbell (HUB.
Comtex SmarTrend(R) - Thu Oct 09, 7:04AM CDT
Hubbell (NYSE:HUB. was downgraded from Outperform to Perform at Oppenheimer today. The stock closed yesterday at $124.20 on volume of 567,000 shares, above average daily volume of 213,000. Potential upside of 0.6% exists for Hubbell, based on a current level of $124.20 and analysts' average consensus price target of $125.00. The stock should find initial support at its 50-day moving average (MA) of $120.90 and further support at its 200-day MA of $118.77.
HUB.B: 112.39 (+0.59)

Hubbell Misses on Q2 Earnings & Revenues but Guides Well - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 23, 10:05AM CDT
Hubbell Inc. (HUB. second quarter earnings of $1.51 per share 39.3% sequentially and 9.8% on a year-over-year basis. Higher volumes, driven partly by acquisitions and improved profitability led to the increase in earnings.
FSLR: 50.99 (-0.97), CHTR: 146.68 (+0.06), SIMO: 22.70 (-0.61), HUB.B: 112.39 (+0.59)

Hubbell's 2Q Earnings Beat Estimate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jul 26, 3:17PM CDT
Hubbell's second quarter earnings of $1.37 per share were above the Zacks Consensus Estimate of $1.30 on the back of a lower tax rate and outstanding share count.
SGMS: 13.83 (+0.96), INVN: 14.53 (-0.42), IT: 84.57 (+0.68), HUB.B: 112.39 (+0.59)

1 Reason to Expect Big Things from Hubbell
Seth Jayson, The Motley Fool - Motley Fool - Tue Jul 23, 12:05AM CDT
Here at The Motley Fool, I've long cautioned investors to keep a close eye on inventory levels. It's a part of my standard diligence when searching for the market's best stocks . I think a quarterly checkup can help you spot potential problems. For...
HUB.B: 112.39 (+0.59)

WESCO Misses Again - Analyst Blog
Sejuti Banerjea - Zacks Investment Research - Mon Apr 22, 8:31AM CDT
WESCO missed the Zacks Consensus Estimate for the first quarter, although revenue growth trends look encouraging.
WCC: 86.55 (+0.01), AVT: 43.84 (+0.26), RELL: 9.91 (-0.02), HUB.B: 112.39 (+0.59)

Hubbell's 1st-quarter net income rises 4 percent
AP - Thu Apr 18, 9:41AM CDT
SHELTON, Conn. (AP) — Hubbell Inc., the maker of electrical products, said Thursday that its first-quarter net profit rose 4 percent, as a recent acquisition helped boost sales.
HUB.B: 112.39 (+0.59), HUB.A: 117.94 (-0.15)

A Hidden Reason Hubbell's Future Looks Bright
Seth Jayson, The Motley Fool - Motley Fool - Thu Feb 21, 8:02AM CST
Here at The Motley Fool, I've long cautioned investors to keep a close eye on inventory levels. It's a part of my standard diligence when searching for the market's best stocks . I think a quarterly checkup can help you spot potential problems....
HUB.B: 112.39 (+0.59)

Kennametal CEO Cardoso Elected to Hubbell Board of Directors
PR Newswire - Fri Feb 08, 7:15AM CST
Kennametal Inc. (NYSE: KMT) Chairman, President and CEO Carlos Cardoso, 55, has been elected to serve as a director of Hubbell Incorporated (NYSE: HUBA, HUBB). He also serves as chairman of industry thought leader MAPI, the Manufacturers Alliance for Productivity and Innovation, as well as on the boards of the National Association of Manufacturers; Stanley Black & Decker; the Fairfield University Charles F. Dolan School of Business Advisory Council; the board of the Allegheny Conference on Community Development; and the University of Pittsburgh Cancer Institute Council.
SWK: 95.83 (-0.05), KMT: 38.94 (-0.02), HUB.B: 112.39 (+0.59), HUB.A: 117.94 (-0.15)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Salveo Home Care Faces Class Action Over Labor Violations

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

DKS Facing Class Action Over Stock Slump Allegations

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Revamping Children's Radiotherapy: Leo Cancer Care's Vision

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Leo Cancer Care's Upright Radiotherapy Milestone

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

IASO's FUCASO Shows Robust Results in 2026 Study

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

AI Memory Growth Pushes Limits at GMIF2026 Summit

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Accuray, Samsung Push Boundaries with Imaging Deal

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Melrose Fire Station Reaches Steel Topping Milestone

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Fuse Oncology Showcases New iRT Workflow at ASTRO

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...